John A. Kraeutler

Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. Its platforms include molecular, immunoassay, urea breath, and blood chemistry. It operates through the Diagnostics and Life Science segments. The Diagnostics segment consists of manufacturing operations for infectious disease and blood chemistry products and the sale and distribution of diagnostics products domestically and abroad. The Life Science segment distributes bulk antigens, antibodies, polymerase chain reaction/ quantitative PCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.

MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ.

ESA Biosciences, Inc. manufactures detection and electrochemistry combined component kits and reagents for laboratories and commercial diagnostics. Its products include coulochem, coulArray detector, pumps and auto samplers. The company was founded in 1968 and is headquartered in Billerica, MA.

The Cincinnati USA Regional Chamber of Commerce operates as a chamber of commerce association. The private company is based in Cincinnati, OH and has subsidiaries in the United States. Jill P. Meyer has been the CEO of the company since 2015.

AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH.

Magellan Biosciences, Inc. engages in the manufacture of medical devices for point-of-care systems, clinical laboratory instruments, and analytical laboratory. The company was founded on May 4, 2005 and is headquartered in North Billerica, MA.